吴晓萍是暨南大学生命科学技术学院研究员，博士生导师。一直致力于细胞因子与创伤修复、肿瘤的基础理论、临床应用及其相关基因工程药物的研发，主要涉及成纤维细胞生长因子（FGF）家族的结构与功能关系、细胞效应与分子调控机制、FGF规模化生产的关键技术、临床应用安全性等方面。吴晓萍： 女 ，暨南大学生命科学技术学院研究员 博导 。近3年主持国家及省部级项目5项。近5年来在国际期刊上发表SCI论文20多篇，其中以第一作者（或通讯作者）在A1类刊物发表5篇，在A2类刊物发表10篇。获国家科学技术发明二等奖1项、广东省科学技术发明一等奖1项和中华医学科技奖一等奖1项。获发明专利2项，参编著作2部。2010年被评为广东省高等学校“千百十工程”省级培养对象。
1996.7～1999.10 广东省昆虫研究所工作1999.10～2005.5 暨南大学医药生物技术研究开发中心工作2005.6～至今 暨南大学组织移植与免疫研究中心工作一直致力于细胞因子与创伤修复、肿瘤的基础理论、临床应用及其相关基因工程药物的研发，主要涉及成纤维细胞生长因子（FGF）家族的结构与功能关系、细胞效应与分子调控机制、FGF规模化生产的关键技术、临床应用安全性等方面。目前制约基因工程药物研发的主要瓶颈问题是基因工程药物的设计、改造及其高通量筛选，而蛋白质构效关系及其作用机制的研究是基因工程药物设计和改造的核心基础。本人十多年来的研究工作一直围绕细胞因子进行，致力于将成纤维细胞生长因子（FGF）的基础研究与临床应用密切结合，在对FGF的结构与功能关系、细胞效应与分子调控机制等基础问题进行深入研究的基础上，一方面通过对FGF进行精细的结构改造和修饰，使改构的FGF更适于临床应用，成功研发了基因工程一类新药“重组人酸性成纤维细胞生长因子”；另一方面构建了细胞因子拮抗肽的筛选平台，从随机肽库中筛选获得了新型的以bFGF/FGFR为靶标的拮抗肽，并对其作用机制进行了深入研究。
1. Cong Wang, Yonglin Yu,Quchou Li, SusuGao, XinlongJia, Xilei Chen, Ruixue Wang, Tao Li, Wenhui Wang, , Xiaokun Li, and Xiaoping Wu*.P7 peptides suppress the proliferation of K562 cells induced by basic fibroblast growth factor.Tumour Biol. 2012. DOI 10.1007/s13277-012-0348-9.2. Yonglin Yu, SusuGao, Quchou Li, Cong Wang, XinqiangLai, Xilei Chen, Ruixue Wang, JingfangDi , Tao Li, Wenhui Wang, Xiaoping Wu*. The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo. J Cancer Res Clin Oncol. 2012. DOI 10.1007/s00432-012-1201-73. Quchou Li, SusuGao, Yonglin Yu, Wenhui Wang, Xilei Chen, Ruixue Wang, Tao Li, Cong Wang, Xiaokun Li,Xiaoping Wu*. A novel bFGF antagonist peptide inhibits breast cancer cell growth. Mol Med Report. 2012, 6(1):210-214.4. Xiaoping Wu*, XinglongJia, YuhuaJi, Cong Wang,, Yonglin Yu, SusuGao, Quchou Li, Xiaokun Li. Effects of a Synthetic bFGF Antagonist Peptide on the Proteome of 3T3 Cells Stimulated with bFGF. Int J Pept Res Ther. 2011, 17(1): 53–59.5. HaishanTian, Lu Tang, Yi Wang, Xiaojie Wang, Lili Guan, Jian Zhang. Xiaoping Wu*, Xiaokun Li. Lactose Induction Increases Production of RecombinantKeratinocyte Growth Factor-2 in Escherichia coli. Int J Pept Res Ther. 2011, 17(2): 123–129.6. Zhifeng Huang, Huiyan Wang, Meifei Lu, Chuanchuan Sun, Xiaoping Wu, Yi Tan, Chaohui Ye, Guanghui Zhu, Xiaojie Wang, Lu Cai, Xiaokun Li A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol. PLoS One. 2011,6(6):e20669.7. Yi Wanghttp://pubs.acs.org/doi/abs/10.1021/jm200017g - notes-1#notes-1, Jian Xiaohttp://pubs.acs.org/doi/abs/10.1021/jm200017g - notes-1#notes-1, Huiping Zhou, Shulin Yang, Xiaoping Wu, Chengxi Jiang, Yunjie Zhao, Donglou Liang, Xiaokun Li, and Guang Liang. A Novel Monocarbonyl Analogue of Curcumin, (1E,4E)-1,5-Bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, Induced Cancer Cell H460 Apoptosis via Activation of Endoplasmic Reticulum Stress Signaling Pathway. J Med Chem. 2011,54(11):3768-78.8. Xiaoping Wu, Qiuxia Yan, Yadong Huang, Huixian Huang, Zhijian Su, Jian Xiao, Yaoying Zeng, Yi Wang, Changjun Nie, Yongguang Yang, Xiaokun Li.Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity.J Cell Mol Med. 2010, 14(1-2): 351-356.9. Cong Wang, Shaoqiang Lin, YanfangNie, XinglongJia, Jing Wang, Jian Xiao, Jianzhang Wu, Xiaokun Li, Xiaoping Wu*. Mechanism of antitumor effect of a novel bFGF binding peptide on human colon cancer cells.Cancer Science. 2010. 101(5): 1212-1218.10. Chengguang Zhao, Ju Yang, Yi Wang, Donglou Liang, Xuyi Yang, Xiaoxia Li, Jianzhang Wu, Xiaoping Wu, Shulin Yang, Xiaokun Li, Guang Liang. Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release in LPS-stimulated RAW 264.7 macrophages. Bioorg Med Chem. 2010, 18(7):2388-93.11. Xiaoping Wu, Haishan Tian, Yadong Huang, Sixian Wu, Xiaoju Liu, Cong Wang, Xiaojie Wang, Zhifeng Huang, Jian Xiao, Wenke Feng, Xiaokun Li. Large-scale production of biologically active human keratinocyte growth factor-2.Appl Microbiol Biotechnol. 2009, 82(3): 439-444.12. Xiaoping Wu, Changjun Nie, ZhifengHuang, YanfangNie, Qiuxia Yan, Yecheng Xiao, Zhijian Su, Yadong Huang, Jian Xiao, Yaoying Zeng, Yi Tan, Wenke Feng, Xiaokun Li. Expression and Purification of Human Keratinocyte Growth Factor 2 by Fusion with SUMO.Mol Biotechnol. 2009, 42(1): 68-74.13. He F, Zeng Y, Wu X, Ji Y, He X, Andrus T, Zhu T, Wang T. Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells. Apoptosis. 2009, 14(10):1212-26.14. Zhifeng Huang, Chunyan Ni, Yanhui Chu, Shanshan Wang, Shulin Yang,Xiaoping Wu, Xiaojie Wang, Xiaokun Li, WenkeFeng, Shaoqiang Lin. Chemical modification of recombinant human keratinocyte growth factor 2 with polyethylene glycol improves biostability and reduces animal immunogenicity. J Biotechnol. 2009, 142(3-4):242-9.15.Yadong Huang, YulanRao, ChengliFeng, Yanmei Li, Xiaoping Wu, Zhijian Su, Jian Xiao, Yechen Xiao, WenkeFeng, Xiaokun Li. High-level expression and purification of Tat-haFGF19-154. ApplMicrobiolBiotechnol, 2008, 77(5): 1015-1022.16. Xiaoping Wu, Xiaoju Liu, Yecheng Xiao, Zhifeng Huang, Jian Xiao, Shaoqiang Lin, Lu Cai, WenkeFeng, Xiaokun Li. Purification and modification by polyethylene glycol of a new human basic fibroblast growth factor mutant-hbFGFSer25,87,92. Journal of Chromatography A, 2007,1161(1-2): 51-55.17. Xiaokun Li, LijuanJiang, Yi Wang, YechengXiao, YadongHuang, QiongfengYao, YongguangYang, Xiaoping Wu*. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.Cancer Lett. 2007, 256(1): 29-32.18. Su Z, Wu X, Feng Y, Ding C, Xiao Y, Cai L, Feng W, Li X. High level expression of human endostatin in Pichiapastoris using a synthetic gene construct.Appl Microbiol Biotechnol. 2007, 73(6):1355-62.19. Huang Z, Zheng Q, Wu X, Su Z, Xu H, Tan Y, Feng W, Li X, Cai L.Enhanced protection of modified human acidic fibroblast growth factor with polyethylene glycol against ischemia/reperfusion-induced retinal damage in rats.Toxicol Lett. 2007, 170(2):146-56.20.Xiaoping Wu,Xiaokun Li,YaoyingZeng,Qing Zheng,Sixian Wu. Site-directed PEGylation of human basic fibroblast growth factor. Protein Expression and Purification,2006, 48(1): 24-27.21.ZhijianSu, YadongHuang, QuannanZhou, ZhilingWu, Xiaoping Wu, Qing Zheng, ChangcaiDing, XiaokunLi.High-level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli.Protein Pept Lett. 2006;13(8):785-92.22.Xiaoping Wu, Zhijian Su, Xiaokun Li, Qing Zheng, Yadong Huang, Hui Yuan. High-level expression and purification of a nonmitogenic form of human acidic fibroblast growth factor in Escherichia coli. Protein Expression and Purification,2005,42(1): 7-11.23. Xiaoping Wu, Xiaokun Li, Zhijian Su, Qing Zheng, HuaXu, Sixian Wu, YaFeng, Wen Zhao. Expression and purification of soluble non-fusion vasostatin in Escherichia coli.Protein and Peptide Letters, 2005, 12(7): 659-661.
承担课题：1. 国家“863”计划 “新型非促分裂重组成纤维细胞生长因子改构体的研究”子课题, 2005.1-2007.12, 项目负责人。2. 国家“863”计划“提高角化生长因子（KGF-2）表达量及稳定性的关键技术研究”子课题, 2008.1-2010.12,项目负责人。3. 国家自然科学基金面上项目, “P7逆转结肠癌细胞化疗耐药的作用机制研究”, 2011.1-2013.12, 项目负责人。4. 国家自然科学基金面上项目, “新型bFGF结合肽拮抗bFGF的作用机制研究”, 2010.1-2012.12, 项目负责人。5. 广东省自然科学基金面上项目, “bFGF活性拮抗短肽的抗肿瘤作用机制研究”, 2010.1-2012.12，项目负责人。6. 广东省科技计划项目, “晶状体蛋白在人角质形成细胞中的凋亡调控作用研究”, 2011.1-2013.12,
荣誉与奖励：1. 国家科学技术发明二等奖：一类新药重组成纤维细胞生长因子关键工程技术及应用.2009.2. 广东省科学技术发明一等奖: 一类新药重组人酸性成纤维细胞生长因子的开发与应用.20073. 中华医学科技奖一等奖：一类新药重组成纤维细胞生长因子应用基础与工程技术研究.20084. 中国药学科学技术一等奖：基因工程一类新药重组成纤维细胞生长因子（rFGF）系列产品的开发与应用. 2007
     